Live
- TN government committee identifies 42 elephant corridors in state
- Ola Cabs CEO Hemant Bakshi steps down, firm announces job cuts
- BJP leader Sambit Patra files nomination for Puri Lok Sabha seat
- Rajiv Pratap Rudy accuses Lalu Prasad of 'killing' developmental schemes in Saran
- Quick action by Telangana Cyber Security Bureau saves citizen's Rs 1 crore
- Types of food diabetics should avoid
- Celebrating National Honesty Day: 20 Quotes to Inspire Integrity
- PNB Housing Finance registers 57 per cent surge in net profit at Rs 444cr for Jan-March quarter
- Theft in Sirsawada village of Tadur mandal
- Manipal Hospitals clinches deal to acquire Kolkata's Medica Synergie
WHO requires additional information to list Covaxin
WHO requires additional information to list Covaxin
The World Health Organisation (WHO) has said "more information" is "required" from Bharat Biotech, which is seeking emergency use listing (EUL) for its Covaxin vaccine for Covid-19
New York/Geneva: The World Health Organisation (WHO) has said "more information" is "required" from Bharat Biotech, which is seeking emergency use listing (EUL) for its Covaxin vaccine for Covid-19.
The latest 'Status of Covid-19 Vaccines within WHO EUL/PQ evaluation process' guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that "more information required". A pre-submission meeting is expected "to be planned May-June 2021," the guidance document said.
According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential. If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely.
Duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer and on those data meeting WHO criteria, according to the agency.
